Serimmune and Mymee Collaborate on Research Study to Better Define the Role of Antibodies in SARS-CoV-2 Symptoms

GOLETA, Calif.--(BUSINESS WIRE)--Serimmune, a leader in understanding the antibody repertoire's role in human disease, and Mymee, a leading provider of digital care programs for reducing persistent symptoms resulting from autoimmune disease, chronic inflammation and long haul COVID, announced today that they will collaborate on a clinical research study to describe...

Click to view original post